# OnCo record oriole (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/oriole/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "oriole", "NCT02680587" ;
  schema:name "ORIOLE"@en ;
  schema:alternateName "ORIOLE"@en, "Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer"@en ;
  schema:description "Treating one to three secondary tumours with precise radiotherapy cut the chance of the cancer progressing within six months from three in five to one in five, and worked best when a PSMA scan showed nothing had been missed."@en ;
  schema:url <https://onco.cc/trials/oriole/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02680587>, <https://doi.org/10.1001/jamaoncol.2020.0147> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-bcr/>, <https://onco.cc/cancers/prostate-mhspc/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/sabr-oligometastases/>, <https://onco.cc/technologies/psma-pet/> ;
  onco:terms <https://onco.cc/terms/oligometastatic/>, <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/psa/> ;
  onco:trials <https://onco.cc/trials/stomp-oligorecurrence/>, <https://onco.cc/trials/sabr-comet/>, <https://onco.cc/trials/propsma/> .